ESMO 2026 – Highlights From Europe’s Largest Cancer Conference: BI Replay

On Demand

Duration: 59 Minutes

Original Date: October 27, 2026

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join Bloomberg Intelligence Director of Research Sam Fazeli, Senior Analyst Max Nisen and the disease specialist team to review key takeaways from the 2026 ESMO conference in Madrid (October 23-27). The team will unpack key data updates including full data for Moderna and Merick’s personalized mRNA therapy intismeran autogene in melanoma, Amgen’s effort to move bispecific tarlatamab in to first line small cell lung cancer and much more.

ESMO 2026 – Highlights From Europe’s Largest Cancer Conference: BI Replay

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.